Sign up
Quantellect · Congress · Congressional Trade

Jonathan L. Jackson sold Tenet Healthcare Corporation (NYSE: THC)

Jonathan L. Jackson sold Tenet Healthcare Corporation (THC), disclosed May 27, 2026

Jonathan L. Jackson sold THC · disclosed May 27, 2026

Jonathan L. Jackson, a IL House member representing District 1, sold $15,001 - $50,000 of Tenet Healthcare Corporation (THC) on April 20, 2026. Filings associated with Jonathan L. Jackson disclosed 4 other THC transactions (2 purchases and 2 sales) in the 12 months before this trade. Shares of THC have risen 41.8% since the first observed purchase on September 3, 2025. The filing was publicly disclosed on May 27, 2026; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Jonathan L. Jackson's complete filing history, visit Jonathan L. Jackson's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on THC break down as 0 strong buy, 17 buy, 1 hold, 0 sell, 0 strong sell.
  • THC carries a Risk Score of 91 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
  • Jonathan L. Jackson sold THC in the amount range of $15,001 - $50,000 on April 20, 2026, filed under the STOCK Act.
  • The filing lists Joint as the transaction owner and was disclosed 37 days after the trade.
  • The asset description in the filing reads 'Tenet Healthcare Corporation Common Stock (THC) [ST].'
  • Filings associated with Jonathan L. Jackson disclosed 4 other THC transactions (2 purchases and 2 sales) in the 12 months before this trade.
  • Shares of THC have risen 41.8% since the first observed purchase on September 3, 2025.
  • THC carried a Q Score of 90.6 in its equity peer group as of September 4, 2026.
  • THC carried a Squeeze Score of 17 as of September 8, 2026.

Did Jonathan L. Jackson buy or sell THC?

The Periodic Transaction Report covers a single sale involving THC on April 20, 2026. The filed amount range is $15,001 - $50,000. The asset description reads 'Tenet Healthcare Corporation Common Stock (THC) [ST]', as submitted by the filer. The report was submitted on May 27, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Jonathan L. Jackson (House)SellTHC$15,001 - $50,000April 20, 2026May 27, 2026

What other THC trades has Jonathan L. Jackson disclosed in the past 12 months?

Filings associated with Jonathan L. Jackson disclosed 4 other THC transactions (2 purchases and 2 sales) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
April 15, 2026SellSpouse$1,001 - $15,000Filing unavailable
February 11, 2026SellSpouse$1,001 - $15,000Filing unavailable
December 10, 2025BuyJoint$15,001 - $50,000Filing unavailable
September 3, 2025BuySpouse$1,001 - $15,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a sale involving THC by Jonathan L. Jackson in the amount range of $15,001 - $50,000, with Joint listed as the owner. It does not establish Jonathan L. Jackson's total holdings in THC, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Tenet Healthcare Corporation Common Stock (THC) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Jonathan L. Jackson's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Jonathan L. Jackson disclosed 4 other THC transactions (2 purchases and 2 sales) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded THC?

Quantellect's current database lists these recent THC disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
No recent disclosures by other members are available.

How has Jonathan L. Jackson's disclosed trading performed?

Jonathan L. Jackson holds a Quantellect Q Score of 35 (mixed), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.

Q Score rank #51 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.

All Jonathan L. Jackson THC trades

TradedTypeSizeReturnEst. profit
April 20, 2026Sell$15,001 - $50,000+38.58%
April 15, 2026Sell$1,001 - $15,000+36.93%
February 11, 2026Sell$1,001 - $15,000+17.10%
December 10, 2025Buy$15,001 - $50,000+34.22%+$11K
September 3, 2025Buy$1,001 - $15,000+41.81%+$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Jonathan L. Jackson buy or sell THC?

According to the disclosure, Jonathan L. Jackson sold THC on April 20, 2026.

What amount was reported for the THC transaction?

The disclosure reports $15,001 - $50,000 for the sale. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated April 20, 2026, and it was disclosed on May 27, 2026.

Where can I see Jonathan L. Jackson's other congressional trades?

Quantellect lists Jonathan L. Jackson's complete disclosed trade history on the member profile. Jonathan L. Jackson's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Q Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.